List of works - Shuta Tomida

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

scientific article

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

scientific article

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells

scientific article published on 21 November 2018

Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.

scientific article published on 21 February 2018

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations

scientific article

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis

scientific article published on 06 October 2018

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies

scientific article published on January 2017

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

scientific article published on 26 July 2017

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

scientific article published on 20 March 2006

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients

scientific article published on July 2004

Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

scientific article published in September 2017

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.

scientific article published on 23 December 2016

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

scientific article (publication date: July 2007)

Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways

scientific article published on 30 November 2010

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system

scientific article

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

scientific article published on March 2004

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

scientific article published in February 2005

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

scientific article

Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.

scientific article published on 22 September 2010

Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.

scientific article

Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.

scientific article published on 21 April 2009

Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.

scientific article

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.

scientific article

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.

scientific article published on 13 January 2017

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.

scientific article

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

scientific article published on 15 April 2018

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.

scientific article published on 13 March 2018

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

scientific article

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

scientific article

List of works by Shuta Tomida

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells

Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients

Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.

Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.

Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.

Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.